Mária Szilasi - Concepedia

Author

Mária Szilasi

Also Known As

Anikó Bohács, Gabor Halmos, M Szilasi, M. Szilasi, Maria Szilasi, Mária Szilasi, Mária Szilasi, Szilasi M, Szilasi, Mária

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

University of Debrecen Semmelweis University Sam Houston State University Gdańsk Medical University Texas A&M University

About

Mária Szilasi is an author at University of Debrecen specializing in medicine, pharmacology, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	535
2	Health Sciences	3	3	92
3	Natural Sciences	3	3	52
4	Engineering	2	2	33
5	Public Health	1	1	18

Mária Szilasi

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
Cisplatin and gemcitabine first-line chemotherapy followed by maintenance gemcitabine or best supportive care in advanced non-small cell lung cancer: A phase III trial Thomas Brodowicz, Maciej Krzakowski, Matjaž Zwitter, Lung Cancer MedicineCancer ManagementPhase Iii TrialMaintenance GemcitabineBronchial Neoplasm	2006	322
CheckMate 171: A phase 2 trial of nivolumab in patients with previously treated advanced squamous non-small cell lung cancer, including ECOG PS 2 and elderly populations Enriqueta Felip, Andrea Ardizzoni, Tudor–Eliade Ciuleanu, European Journal of Cancer	2020	155
Inhaled Carbon Monoxide Confers Antiinflammatory Effects against Ventilator-induced Lung Injury Tamás Dolinay, Mária Szilasi, Mingyao Liu, American Journal of Respiratory and Critical Care Medicine	2004	144
Mitogen-Activated Protein Kinases Regulate Susceptibility to Ventilator-Induced Lung Injury Tamás Dolinay, Wei Wu, Naftali Kaminski, PLoS ONE	2008	80
Serum human epididymis protein 4 (HE4) as a tumor marker in men with lung cancer Béla Nagy, Harjit Pal Bhattoa, Zoltán Steiber, Clinical Chemistry and Laboratory Medicine (CCLM)	2014	49
Extrafine Beclomethasone/formoterol compared to Fluticasone/salmeterol Combination Therapy in COPD Dave Singh, Gabriele Nicolini, Eddi Bindi, BMC Pulmonary Medicine	2014	42
Distinct groups of multidrug resistance modulating agents are distinguished by competition of P-glycoprotein-specific antibodies Henrietta Nagy, Katalin Goda, Ferenc Fenyvesi, Biochemical and Biophysical Research Communications P-glycoprotein-specific AntibodiesMedicineGlycobiologyImmunologyResistance Mutation (Virology)	2004	40
Nivolumab in previously treated patients with metastatic squamous NSCLC: Results of a European single-arm, phase 2 trial (CheckMate 171) including patients aged ≥70 years and with poor performance status Sanjay Popat, Andrea Ardizzoni, T-E. Ciuleanu, Annals of Oncology European Single-armPreclinical TherapeuticsUrologyMedicineCancer Management	2017	40
Alteration of the irisin&ndash;brain-derived neurotrophic factor axis contributes to disturbance of mood in COPD patients Csaba Papp, Krisztián Pák, Tamás Erdei, International Journal of COPD	2017	37
New insights into the impact of primary lung adenocarcinoma location on metastatic sites and sequence: A multicenter cohort study Thomas Klikovits, Zoltán Lohinai, Katalin Fábián, Lung Cancer Metastatic SitesCancer EpidemiologyMedicineMultiple Pulmonary NodulePathology	2018	37

Page 1